etoposide has been researched along with gastrin-releasing peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haslett, C; Jodrell, D; Lucas, CD; MacKinnon, AC; Sethi, T; Tufail-Hanif, U | 1 |
| Chung, DH; Gillory, LA; Kang, J; Paul, P; Qiao, J | 1 |
2 other study(ies) available for etoposide and gastrin-releasing peptide
| Article | Year |
|---|---|
Expression of V1A and GRP receptors leads to cellular transformation and increased sensitivity to substance-P analogue-induced growth inhibition.
Topics: Animals; Arginine Vasopressin; Cell Division; Cell Transformation, Neoplastic; Cricetinae; Cricetulus; Etoposide; Gastrin-Releasing Peptide; Humans; Peptide Fragments; Receptors, Neuropeptide; Substance P; Transfection; Tumor Cells, Cultured | 2005 |
Targeting gastrin-releasing peptide as a new approach to treat aggressive refractory neuroblastomas.
Topics: Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Etoposide; Gastrin-Releasing Peptide; Humans; Neuroblastoma; Poly(ADP-ribose) Polymerases; RNA, Small Interfering; Transfection; Tumor Suppressor Protein p53; Vincristine | 2011 |